INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Take-Two Interactive Software, Inc. - TTWO — Neutral
TTWO GlobeNewsWire — June 02, 2025NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Take-Two Interactive Software, Inc. (“Take-Two” or the “Company”) (NASDAQ: TTWO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDX — Neutral
ARDX GlobeNewsWire — June 02, 2025NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ: ARDX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Chris Nassetta, CEO of Hilton Worldwide, said on Monday that he doesn't expect the macro and geopolitical environment to impact the hospitality giant's growth over the next 2-3 years.

OGN INVESTOR DEADLINE: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit — Neutral
OGN PRNewsWire — June 02, 2025SAN DIEGO , June 2, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that the Organon class action lawsuit – captioned Hauser v. Organon & Co., No.

Lost Investment in Eos Energy Enterprises, Inc. (EOSE)? Levi & Korsinsky Launches Securities Fraud Investigation — Neutral
EOSE Accesswire — June 02, 2025NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Eos Energy Enterprises, Inc. ("Eos Energy Enterprises, Inc.") (NASDAQ:EOSE) concerning possible violations of federal securities laws. Eos disclosed in a filing with the U.S. Securities and Exchange Commission on May 27, 2025, that it had "terminated the employment of its Chief Financial Officer (‘CFO'), Eric Javidi, effective immediately.

Levi & Korsinsky Urges UroGen Pharma Ltd. (URGN) Shareholders to Act Before Lead Plaintiff Deadline July 28, 2025 — Neutral
URGN Accesswire — June 02, 2025NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=151319&wire=1&utm_campaign=18 or contact Joseph E.

Levi & Korsinsky Investigating Whether Rocket Pharmaceuticals, Inc. (RCKT) Misled Investors - Securities Law Violations Possible — Neutral
RCKT Accesswire — June 02, 2025NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rocket Pharmaceuticals, Inc. ("Rocket Pharmaceuticals, Inc.") (NASDAQ:RCKT) concerning possible violations of federal securities laws. Rocket issued a press release on May 27, 2025, "announcing an update related to RP-A501, its investigational gene therapy for Danon disease.

URGN Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against UroGen Pharma Ltd. — Neutral
URGN Accesswire — June 02, 2025SAN DIEGO, CA / ACCESS Newswire / June 2, 2025 / Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired UroGen Pharma Ltd. (NASDAQ:URGN) securities between July 27, 2023 and May 15, 2025.

Texas Class-Action Suit Against Lottery.com Voluntarily Dismissed by Plaintiff — Neutral
LTRY GlobeNewsWire — June 02, 2025FORT WORTH, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- Lottery.com Inc. (Nasdaq: LTRY, LTRYW) (“Lottery.com” or the “Company”), a leading technology company in digital lottery and sports entertainment, was notified that Plaintiff Dawn Nettles filed a notice on May 30, 2025 that she is “taking a Nonsuit Without Prejudice Against All Parties Effective Immediately” (the “Notice”) in Case No. 25-BC11A-0026; Dawn Nettles vs. Rook TX LP, Gary N. Grief, Lottery.com Inc. (The “Suit”).

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART — Neutral
IART GlobeNewsWire — June 02, 2025NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation (“Integra” or the “Company”) (NASDAQ: IART). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Jay Jacobs, Blackrock's U.S. Head of Equity ETFs, joins Dom Chu on “Halftime” to talk about the strength of AI ETFs and Bitcoin ETFs seeing big outflows.

Perplexity Samsung deal aims to rival OpenAI's Apple partnership — Positive
AAPL MSFT CNBC Television — June 02, 2025CNBC's Deirdre Bosa joins 'Money Movers' to discuss the AI battle for device default distribution.

Palantir's AIP Platform Sees Soaring Adoption Across Enterprises — Positive
PLTR Zacks Investment Research — June 02, 2025PLTR's AIP drives a 71% jump in U.S. commercial revenue as enterprises fast-track AI deployment at scale.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR — Neutral
CAPR GlobeNewsWire — June 02, 2025NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

7-10% Yielding Big Dividend Powerhouses To Turbocharge Your Retirement Income — Positive
AMLP ARCC BIZD BXSL EPD ET GBDC KMI PAA SCHD Seeking Alpha — June 02, 2025High-yield, blue-chip stocks are the holy grail of retiring on dividends. I share some of my favorite 7-10% yielding blue chips that look like attractive picks for retirees. I also share some of the risks to keep in mind.

UnitedHealth added 800,000 Medicare Advantage members in Q1 FY 2025, despite rising utilization and CMS model disruption in the segment. Optum Health is on track to serve 5.4 million value-based care patients in FY 2025, driving higher-margin, preventive-focused revenue growth. Optum contributes ~43% of UnitedHealth's operating income, with Optum Rx achieving 14% topline growth and a $140B annual revenue run-rate.

Advisors may be able to enhance client portfolios with an allocation to value stocks. An investor may consider the Fidelity Value Factor ETF (FVAL) for exposure to a diversified basket of large- and midcap U.S.

The BEA's core Personal Consumption Expenditures (PCE) Price Index for April showed that core inflation continues to be above the Federal Reserve's 2% long-term target at 2.5%. The March core Consumer Price Index (CPI) release was higher, at 2.8%.

Disney is laying off several hundred people as the company grapples with a declining TV business — Negative
DIS Business Insider — June 02, 2025Disney is laying off several hundred employees globally amid declining TV audiences. The layoffs affect marketing, publicity, casting, and corporate finance, mainly in the US.
